Compliance and Auditing

MMS helps Sponsors meet the demands of the ever-shifting global regulatory environment.

The MMS QMS stands out as the most organized, efficiently executed, and highest quality QMS reviewed across my many company audits. Excellent Job!
President
Midsize Pharma

MMS recognizes the importance of implementing fit-for-purpose policies, procedures, personnel training, vendor management, vendor oversight, and auditing activities. Additionally, we understand that compliance with regulatory requirements can be especially difficult in this era of global footprints and a hybrid workforce.

To support you better, we provide a full suite of Compliance and Auditing Services, including the ability to perform audits remotely, in-person, or via a hybrid combination of these approaches as required by on-the-ground activities and auditee availability to all Sponsors in the pharmaceutical industry.

Global Auditors to Support Your Compliance needs

When you choose MMS as your partner of choice for Compliance and Auditing Services, adaptable industry experts backed by strong processes will be assigned to your projects.

We are known for our well-defined processes and relentless commitment to delivering the highest quality results on time, consistently.

We assign each Sponsor a dedicated point of contact that manages the delivery of audit tasks to drive timelines, ensuring the consistency of high-quality deliverables and transparency of KPI reporting.

We provide best-in-class reports in a third of the time (33 percent less) than the industry standard: 10 business days for standard audits and 45 calendar days for mock inspection peer-reviewed report delivery.

Our GxP specialists located in the US, Europe, the UK, Latin America, Asia-Pacific, and Africa are available for global assignments.

Types of Audits Across GxP Environments

Investigator Site Audits

  • Routine, Targeted and For-Cause
  • Inspection Preparation/Training
  • Phases I-IV
  • Mock Inspections/Pre-Approval
  • Inspections

Vendor Audits

  • Routine, Targeted, For-Cause
  • Qualification/Re-Qualification
  • Sponsor Internal, Process, Oversight, and Gap Assessments
  • CRO
  • Project Management
  • Monitoring and Site Management
  • Data Management
  • Statistical Programming/Biostatistics
  • Medical Writing
  • Clinical Trial
  • Supply/Distributors/Depots
  • Interactive Response Technology
  • Translation Services
  • Archive Facilities
  • Medical Monitoring
  • Centralized Imaging
  • Central, Bioanalytical and/or Specialty labs
  • Drug Substance/Biologics
  • Manufacturers

Document Audits

  • Case Report Forms
  • Informed Consent
  • Investigator Brochures
  • Clinical Study Reports
  • Development Safety Update Reports
  • Protocol Audits (all Phases)
  • Trial Master File Audits (paper/electronic)

System Audits

  • Bespoke audits
  • Sponsor System/process audits
  • Clinical Database audits
  • Pharmacovigilance systems
Inspection Readiness and Preparations

Give your organization the ability to respond confidently to global regulatory authority inspections or investigation requests with inspection readiness and preparations by MMS. Our experts provide comprehensive pre-inspection reviews of facilities, processes, documents, and staff member preparedness including mock inspections.

MMS audit readiness ensures that all Sponsor colleagues are prepared for the variety and volume of requests accompanying any regulatory inspection at their plant or facility, third-party vendors, suppliers, laboratories, clinical sites, and/or contract manufacturers. Additionally, process, document and facility audits are conducted in conjunction, providing the added benefit of uncovering potential observations and allowing for resolution or mitigation before the actual regulatory authority inspection occurs.

Uncovering and addressing findings at this primary juncture provides Sponsors with the added security of knowing that all inspection and compliance potential areas are under control early.

Compliance Services

Quality is critical during all phases of pharmaceutical development and becomes a mandatory requirement as the product moves to a marketed product. MMS quality experts are able to navigate your teams for building, auditing, improving, or defending your Quality Management Systems.

Why MMS for Your Quality Needs?



When you choose MMS for your Compliance and Auditing services, you will work with experienced Quality professionals backed by strong processes.

Quality resources are necessary but can be cost prohibitive as full-time overheads. MMS can provide years of experience with multiple areas of expertise in quality and resourcing flexibility.

We assign each sponsor a dedicated point of contact with at least 10 years of experience working within quality.

Your point of contact manages the deliverable to meet timelines, ensuring consistently high quality of deliverables and transparency of KPI reporting.

MMS is known for our well-defined processes with robust internal systems support and our relentless commitment to consistently delivering the highest quality results on time.
We have GxP compliance service staff located in Europe and the US available for global assignments.

Quality Management Systems (QMS) Development

Uniquely focused on Quality Assurance, MMS supports a wide range of Sponsors in need of Quality Management Systems (QMS) development, including those completing large-scale mergers and acquisitions that may need to streamline, integrate, and/or improve an existing QMS. MMS experts can provide the support to develop systems & tools for all QA processes.

At MMS, there is no one-size-fits-all approach to providing QMS services – as all organizations have inherent differences. This forward-thinking, risk-based approach ensures that Sponsors gain efficiency and reduce the risk of non-compliance with customized programs for:

  • QMS Evaluation and Gap Assessment, by understanding the strengths and weaknesses of your current quality management system.
  • Procedure Support, including a thorough evaluation and customized QMS project plan that ensures end-to-end compliance through policies, process maps, standard operating procedures (SOPs), work instructions, and associated forms and templates.
  • Organizational Structure Support, including implementing organizational charts, position descriptions, development of strategic business planning framework, and key performance indicators.
Training Coordination

Training in a compliance setting can be complex. Sponsors have to demonstrate they have qualified personnel for the position assigned and that they understand the quality responsibilities of their job. Once qualified, Sponsors must repeatedly educate and provide proof of continual proficiency.

A well-thought-out and managed training program is the pillar of a quality program. Training encompasses not just the job to be done but an understanding of the regulations / accreditations and the quality policies established.

MMS can serve as a training partner for all GxP Training needs, as follows:

  • Perform a gap assessment of the current training program to evaluate training needs, training requirements, the effectiveness of the training, and the documentation needed
  • Create an audit-ready training program that will provide evidence that you meet and exceed quality requirements for qualifying employees and maintaining proficiency
  • Develop Training Standard Operating Procedures and training documentation
· Create training modules or courses
· Create GxP training or Inspection Readiness courses to be presented by our staff or yours
  • Implement an electronic Learning Management System (LMS) to track all training requirements and completed training in one location
Inspection Support

Due to a shift in qualifying contract services through audits, the amount of time spent hosting audits has significantly increased. MMS can provide the resources to manage your hosted audit program.

MMS has experienced employees that have hosted regulatory and accreditation body audits. We will partner with you through our quality programs to build, improve, and defend your quality management systems.

MMS inspectional support can include:

  • Assist in preparation for a scheduled or unscheduled audit (inspection readiness)
  • Provide comprehensive pre-inspection reviews of facilities, processes, documents, and staff member preparedness
  • Train employees on hosting audit
  • Create inspection procedures and documentation
Regulatory Defense

FDA 483 observations and warning letters are openly available and can cause concern to the public or be used by competitors as an advantage. Addressing these issues swiftly and sufficiently is extremely important and is best handled by experts in the quality system. MMS is a trusted CRO of choice that can provide resources to:

  • Evaluate the finding, investigate root cause, and identify risks
  • Prepare a corrective action plan
  • A timely draft response to the finding


Suggested For You

perspectives

October 8th, 2024

Diversity Action Plan Guidance Part I: Implications for Sponsors

webinar

October 22nd, 2024

Optimal Strategies to Protect Commercially Confidential Information (CCI) in Clinical Documents and Report Trial Results Under Revised EU-CTIS Transparency Rules

perspectives

September 30th, 2024

Meet the Leaders Driving MMS’s European Growth

perspectives

September 30th, 2024

The Future of Data Management and Biostatistics: Trends and Technologies Shaping the Industry

perspectives

September 24th, 2024

Embracing Quality Management Maturity (QMM) at the Cornerstone of the Pharmaceutical Industry

perspectives

September 11th, 2024

From Historical Precedent to Modern Approvals: Lessons Learned on OTC Drug Products for FDA OMORs

webinar

September 26th, 2024

Regulatory Pathways for Nonprescription Drugs: A Deep Dive into OTC Monograph Reform and FDA Guidance

perspectives

September 4th, 2024

Email Security – Navigating Through the Process of Validation and Compliance with Healthcare Business Stakeholders

perspectives

August 27th, 2024

Optimizing Oncology Drug Development: FDA Expedited Pathways, Real-Time Review, and Global Programs

regulatory intelligence

August 27th, 2024

Recent Guidance on Diversity Action Planning

regulatory intelligence

August 26th, 2024

Oncology Programs at the FDA

regulatory intelligence

August 26th, 2024

Three Key Take Reflections on the Recent Donanemab Approval